The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.00
Ask: 143.50
Change: -2.25 (-1.56%)
Spread: 2.50 (1.773%)
Open: 144.00
High: 144.00
Low: 142.00
Prev. Close: 144.50
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Mar 2024 16:00

RNS Number : 5191F
Redcentric PLC
04 March 2024

Redcentric plc

Director/PDMR Shareholdings

Redcentric plc (AIM:RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, received notification from Kestrel Partners LLP ("Kestrel") that on 29 February and 1 March 2024 it purchased, on behalf of its discretionary client accounts, an aggregate of 3,018 ordinary shares of 0.1 pence each ("Ordinary Shares") in the Company at an average price of £1.3167 per Ordinary Share.

Mr Oliver Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 16,715,306 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 15,992,271 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 32,707,577 Ordinary Shares in the Company, which represents approximately 20.67 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,715,306

10.56%

Indirect

JIM Nominees Limited

464,310

0.29%

Indirect

Bank of New York Nominees Ltd

12,471,770

7.88%

Indirect

Northern Trust Company AVFC

3,056,191

1.94%

For further information contact:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

+44 (0) 800 983 2522

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0) 20 7220 0500

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP

2

Reason for the notification

a)

Position/status

PCA - Oliver Scott (non-executive director Redcentric plc)

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

0.1 pence Ordinary Shares

ISIN: GB00B7TW1V39

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Transfer

Purchase

29 February 2024

Price(s)

Volume(s)

£1.3150

1,018

1 March 2024

Price(s)

Volume(s)

£1.3175

2,000

d)

Aggregated information

- Aggregated volume

- Price

Purchase Total of 3,018 Ordinary Shares at a price of £1.3167

e)

Date of the transaction

29 February & 1 March 2024

f)

Place of the transaction

London AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHJIMATMTTMBJI
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.